Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)


Dr. Aideen Ryan

The immunologic profile of allogenic differentiated MSCs for therapeutic applications, Immunology & Cancer cell biology, Immunology & Mechanisms of colon cancer metastasis

View info >>

Andreia Ribeiro

Effect of hypoxia on stromal cell ECM to maintain stemness

View info >>

Prof. Thomas Ritter

Personal Professor in Medicine
Vice-Dean for Research, College of Medicine, Nursing and Health Sciences

Cellular Immunology, Cornea Transplantation, Gene Therapy.

View info >>

Grace O'Malley

Tumour-stromal interactions in colon cancer

View info >>

Dr. Bernard Mahon

Mucosal Immunology Laboratory, NUI Maynooth

Examination of the neonatal immune response. We explore how adult derived stem cells can be transplanted even when mismatched (allogeneic transplantation).

View info >>

Prof. Rhodri Ceredig

I am a basic cellular and molecular immunologist whose approach to immunology has been heavily influenced by experimental hematology, that is that lymphocytes are the progeny of hematopoietic stem cells and that their development follows many of the general rules of hematology. For my PhD (1980), carried out at the Walter and Eliza Hall Institute, Australia in the group of Prof. Don Metcalf, I characterized the development of functional T lymphocytes in the thymus. For my post-doctoral studies (1980-85) at the Ludwig Institute for Cancer Research, Lausanne, Switzerland I was one of the first to combine flow cytometry, monoclonal antibodies and limiting dilution to quantify a T cell response in vitro. We also identified for the first time, early T cell progenitors in the thymus. In Canberra, Australia (1985-1989) I was responsible for establishing a functional flow cytometry facility at the John Curtin School of Medical Research. With Peter Doherty (Nobel Laureate), we dissected the inflammatory infiltrate in mouse lymphocytic choriomeningitis virus infection and showed that this immune response in vivo obeyed the now-accepted rules of MHC restriction. Whilst Professor of Immunology at the European School of Biotechnology, Université Louis Pasteur, Strasbourg, France (1989-1994) in an institute directed by Prof. Pierre Chambon, I learnt how molecular biology could impact on my own research interests. There, we generated a transgenic mouse over-expressing the cytokine Interleukin-7 (IL-7), a molecule involved both in lymphocyte development and survival. Since that time (1993), I have focused most of my research interest on IL-7. From 2003-2008, I was a guest scientist in the group of Prof. Ton Rolink at the University of Basel, Switzerland. Here, I collaborated with scientists in Basel investigating the immunological properties of mesenchymal stem cells (MSC), the cells that constitute the research focus of REMEDI. Recently, with colleagues in Birmingham and Basel, I have become interested in more general aspects of lymphocyte development and hematopoietic lineage commitment.

View info >>

Joana Cabral

Immunology and Regenerative Medicine/Glycosylation

View info >>

Prof. Matthew Griffin

Professor of Transplant Biology

Immunological Properties of Dendritic Cells in Acute Kidney Injury.
Interactions Between Dendritic Cells and T-cells in Acute Renal Obstruction.

View info >>

Dr. Sweta Rani

Human MSC-secreted vesicles as a novel topical treatment for inflammatory diseases

View info >>

Senthilkumar Alagesan

Senthil's research aims to understand how immuno-suppressive drugs and cells can interact with mesenchymal stem cells (MSCs).

View info >>

Serika Naicker

Characterization of PBMCs for Chronic Kidney Disease

View info >>